These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 114736)

  • 41. Macrophage receptors for migration inhibitory factor (MIF), migration stimulatory factor (MSF), and agglutinating factor.
    Fox RA; Gregory DS; Feldman JD
    J Immunol; 1974 May; 112(5):1867-72. PubMed ID: 4594418
    [No Abstract]   [Full Text] [Related]  

  • 42. Induction of macrophage disappearance reaction by immunoadsorbed MIF.
    Ochiya T; Baba T; Mizushima A; Onozaki K; Yaoita H
    Cell Immunol; 1982 Aug; 71(2):346-52. PubMed ID: 6754101
    [No Abstract]   [Full Text] [Related]  

  • 43. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
    Remold HG; Mednis AD
    J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
    Fahlbusch B; Zschiesche W
    Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production of migration-inhibitory factor by a human T-lymphoblast cell line.
    Remold HG; Mednis A; Kawaguchi T; Bersch N; Golde DW
    Cell Immunol; 1983 Jun; 78(2):305-13. PubMed ID: 6345005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of four lymphocyte activation products of guinea pig and their association with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Mol Immunol; 1980 May; 17(5):555-64. PubMed ID: 7012583
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on human migration inhibitory factor: characterization of three molecular species.
    Weiser WY; Greineder DK; Remold HG; David JR
    J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human migration inhibitory factor: purification and immunochemical characterization.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    J Exp Med; 1978 Feb; 147(2):541-53. PubMed ID: 75241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The enhancement of MIF activity by inhibition of macrophage associated esterases.
    Remold HG
    J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
    [No Abstract]   [Full Text] [Related]  

  • 52. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Oki S; Hirose S; Higuchi M; Osawa T
    Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).
    Bernhagen J; Mitchell RA; Calandra T; Voelter W; Cerami A; Bucala R
    Biochemistry; 1994 Nov; 33(47):14144-55. PubMed ID: 7947826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-yield expression and purification of recombinant human macrophage migration inhibitory factor.
    Mozetic-Francky B; Cotic V; Ritonja A; Zerovnik E; Francky A
    Protein Expr Purif; 1997 Feb; 9(1):115-24. PubMed ID: 9116493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of C-reactive protein on peritoneal macrophages. I. Human C-reactive protein inhibits migration of guinea pig peritoneal macrophages.
    Miyagawa N; Okamoto Y; Miyagawa S
    Microbiol Immunol; 1988; 32(7):709-19. PubMed ID: 3057332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.
    Bernhagen J; Bacher M; Calandra T; Metz CN; Doty SB; Donnelly T; Bucala R
    J Exp Med; 1996 Jan; 183(1):277-82. PubMed ID: 8551232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody.
    Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T
    Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441
    [No Abstract]   [Full Text] [Related]  

  • 60. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.
    Nishihira J; Kuriyama T; Nishino H; Ishibashi T; Sakai M; Nishi S
    Biochem Mol Biol Int; 1993 Dec; 31(5):841-50. PubMed ID: 8136702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.